KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+3.24%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$218M
AUM Growth
+$218M
Cap. Flow
-$11.4M
Cap. Flow %
-5.23%
Top 10 Hldgs %
95.32%
Holding
13
New
1
Increased
6
Reduced
5
Closed
–

Top Buys

1
VNDA icon
Vanda Pharmaceuticals
VNDA
$3.74M
2
EXEL icon
Exelixis
EXEL
$2.5M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
$1.64M
4
BNTX icon
BioNTech
BNTX
$988K
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$846K

Top Sells

1
UTHR icon
United Therapeutics
UTHR
$12.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
$4.88M
3
BIIB icon
Biogen
BIIB
$2.38M
4
CAH icon
Cardinal Health
CAH
$1.77M
5
MURA icon
Mural Oncology
MURA
$40.7K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$10.1B
$37.7M 17.31% 1,677,393 +111,253 +7% +$2.5M
UTHR icon
2
United Therapeutics
UTHR
$13.8B
$37.7M 17.29% 118,208 -38,506 -25% -$12.3M
BIIB icon
3
Biogen
BIIB
$19.4B
$28.7M 13.18% 123,785 -10,283 -8% -$2.38M
TARO
4
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$28M 12.83% 650,089 +2,221 +0.3% +$95.5K
CAH icon
5
Cardinal Health
CAH
$35.5B
$21.4M 9.83% 217,656 -18,000 -8% -$1.77M
ENTA icon
6
Enanta Pharmaceuticals
ENTA
$180M
$16.2M 7.45% 1,251,338 +126,752 +11% +$1.64M
JAZZ icon
7
Jazz Pharmaceuticals
JAZZ
$7.75B
$11.6M 5.35% 109,076 +7,925 +8% +$846K
BNTX icon
8
BioNTech
BNTX
$24B
$10.6M 4.88% 132,293 +12,293 +10% +$988K
REGN icon
9
Regeneron Pharmaceuticals
REGN
$61.5B
$8.25M 3.79% 7,853 -4,641 -37% -$4.88M
SNY icon
10
Sanofi
SNY
$121B
$7.46M 3.43% 153,832 +2,873 +2% +$139K
ALKS icon
11
Alkermes
ALKS
$4.78B
$6.21M 2.85% 257,554 – –
VNDA icon
12
Vanda Pharmaceuticals
VNDA
$279M
$3.74M 1.72% +662,166 New +$3.74M
MURA icon
13
Mural Oncology
MURA
$35.7M
$236K 0.11% 75,057 -12,944 -15% -$40.7K